Preferences for HIV Preexposure Prophylaxis Products Among Black Women in the U.S.

Whitney C. Irie, Sarah K. Calabrese, Rupa Patel, Kenneth H. Mayer, Elvin H. Geng, Julia L. Marcus

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


In a nationwide sample of Black women in the U.S., we assessed preferences for HIV preexposure prophylaxis (PrEP) products, including long-acting injectable (LAI) PrEP and once-daily oral PrEP. Among 315 respondents, 32.1% were aware of PrEP and 40.6% were interested in using it; interest increased to 62.2% if PrEP were provided for free. Oral PrEP was the preferred option (51.1%), followed by LAI PrEP (25.7%), vaginal gel (16.5%), and vaginal ring (6.7%). When examining oral and LAI PrEP alone, most (62.7%) preferred oral PrEP. LAI PrEP was more likely to be preferred among respondents with concerns about healthcare costs or PrEP-related stigma, and among those who reported inconsistent condom use and multiple sexual partners. Although most Black women preferred oral PrEP, LAI PrEP may be appealing to a subset with social and structural barriers to PrEP use, such as cost and stigma, and those at increased risk of HIV infection.

Original languageEnglish
Pages (from-to)2212-2223
Number of pages12
JournalAIDS and Behavior
Issue number7
StatePublished - Jul 2022


  • Black women
  • Cabotegravir
  • HIV prevention
  • Long-acting injectable (LAI)
  • Preexposure prophylaxis (PrEP)


Dive into the research topics of 'Preferences for HIV Preexposure Prophylaxis Products Among Black Women in the U.S.'. Together they form a unique fingerprint.

Cite this